KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
This publication is to help the audit committee members and finance directors monitor the likely regulatory and financial reporting changes and their potential effect on the company.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Submit an enquiry about our services, industry practices, or get in touch with one of our professionals.